GLAUKOS
Glaukos Corporation is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma, one of the world’s leading causes of blindness. They have pioneered Micro-Invasive Glaucoma Surgery, or MIGS, in order to revolutionize the traditional glaucoma treatment and management paradigm. They launched the iStent®, their first MIGS device, in the United States in 2012. They are leverag... ing their platform technology to build a comprehensive and proprietary portfolio of injectable micro-scale therapies designed to address the complete range of glaucoma disease states and progression. They believe the iStent® is the smallest medical device ever approved by the Food and Drug Administration, or FDA, measuring 1.0 mm long and 0.33 mm wide. In June 2015, they completed an initial public offering and their shares are now traded on the New York Stock Exchange under the ticker symbol “GKOS”. The company was founded in 1998 and is based in San Clemente, California.
GLAUKOS
Industry:
Health Care Medical Wellness
Founded:
1998-01-01
Address:
San Clemente, California, United States
Country:
United States
Website Url:
http://www.glaukos.com
Total Employee:
251+
Status:
Active
Contact:
19493679984
Total Funding:
121 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network Wordpress Plugins Nginx
Similar Organizations
BetterNight
BetterNight is providing telehealth-based sleep solutions.
Big Health
Big Health is a digital therapeutics company operating a healthcare portal to offer behavioral programs for mental health issues.
CEL-SCI
CEL-SCI is a biotechnology company developing immunotherapy products for the treatment of cancer and other infectious diseases.
ComplexCare Solutions
ComplexCare Solutions is a health services company integrating care for complex, elderly, special needs, and dually-eligible individuals.
Minerva Surgical
Minerva Surgical is a medical device start-up company developing medical devices for women’s healthcare.
IVERIC bio
IVERIC bio is a biopharmaceutical company developing novel therapies for age-related macular degeneration.
UnitedHealth Group
UnitedHealth Group is a healthcare insurance company that offers health technology, health financial, and pharmacy services.
Current Advisors List
Board_member
2010-12-01
Board_member
2007-01-01
Board_member
Advisor
Board_member
Advisor
Advisor
Advisor
Current Employees Featured
Mory Gharib Co-Founder @ Glaukos
Co-Founder
Thomas W. Burns President & Chief Executive Officer @ Glaukos
President & Chief Executive Officer
2017-06-01
Richard A. Hill Co-Founder and Member of Scientific Advisory Board @ Glaukos
Co-Founder and Member of Scientific Advisory Board
Michele Allegretto Senior Vice President, Human Resources @ Glaukos
Senior Vice President, Human Resources
Craig Sherman Angel Investor @ Glaukos
Angel Investor
2010-12-01
Mark Rhein Head of Talent and Learning @ Glaukos
Head of Talent and Learning
2020-11-01
Chris M. Calcaterra Chief Operating Officer @ Glaukos
Chief Operating Officer
2017-02-01
Gabriella Szekely Vice President, Research and Development, Combination Pharmaceutical Products @ Glaukos
Vice President, Research and Development, Combination Pharmaceutical Products
Joseph E. Gilliam Chief Financial Officer @ Glaukos
Chief Financial Officer
2017-05-01
Olav Bergheim Co-founder @ Glaukos
Co-founder
Founder
Stock Details
Acquisitions List
Date | Company | Article | Price |
---|---|---|---|
2019-11-21 | Avedro | Avedro acquired by Glaukos | N/A |
2019-06-19 | DOSE Medical Corp. | DOSE Medical Corp. acquired by Glaukos | 2.5 M USD |
Investors List
Frazier Healthcare Partners
Frazier Healthcare Partners investment in Series F - Glaukos
Domain Associates
Domain Associates investment in Series F - Glaukos
Meritech Capital Partners
Meritech Capital Partners investment in Series F - Glaukos
OrbiMed
OrbiMed investment in Series F - Glaukos
InterWest Partners
InterWest Partners investment in Series F - Glaukos
Versant Ventures
Versant Ventures investment in Series F - Glaukos
Montreux Equity Partners
Montreux Equity Partners investment in Series F - Glaukos
OrbiMed
OrbiMed investment in Series E - Glaukos
Domain Associates
Domain Associates investment in Series E - Glaukos
Versant Ventures
Versant Ventures investment in Series E - Glaukos
Official Site Inspections
http://www.glaukos.com Semrush global rank: 1.91 M Semrush visits lastest month: 11.4 K
- Host name: 143.191.188.35.bc.googleusercontent.com
- IP address: 35.188.191.143
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York

More informations about "Glaukos"
Advancing the Treatment of Ophthalmic Diseases
Glaukos is committed to investing in the future of ophthalmology to transform standards of care and improve patient lives. We’ve achieved many firsts in clinical studies and over the past several years, Glaukos has reinvested …See details»
Home | Glaukos
At Glaukos, we strive to continuously improve as responsible corporate citizens. We are dedicated to helping people in need, in our own community and beyond. We invest time and resources …See details»
Glaukos - Crunchbase Company Profile & Funding
Glaukos Corporation is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma, one of the world’s leading …See details»
Glaukos - Investor Relations
Nov 8, 2024 Contact Us. Glaukos Corporation One Glaukos Way Aliso Viejo, CA 92656. 949-481-0510 Send Email Fax: 949-367-9984See details»
Governance & Sustainability - Executive Management - Glaukos
Contact Us. Glaukos Corporation One Glaukos Way Aliso Viejo, CA 92656. 949-481-0510 Send Email Fax: 949-367-9984See details»
Glaukos Corp Company Profile - GlobalData
Glaukos’ iStent is used in conjunction with cataract surgery. Glauko’s iStent improves outflow by creating a patent bypass between the anterior chamber and Schlemm’s canal. The company …See details»
Glaukos Company Profile - Office Locations, Competitors ... - Craft
Oct 29, 2024 Glaukos has 5 employees across 16 locations and $314.71 m in annual revenue in FY 2023. See insights on Glaukos including office locations, competitors, revenue, financials, …See details»
Governance & Sustainability - Board of Directors - Glaukos
Before joining Invitrogen, Mr. Hoffmeister spent 20 years with McKinsey & Company as a senior partner serving clients in the healthcare, private equity and chemical industries on issues of …See details»
Glaukos Corp - Overview, News & Similar companies - ZoomInfo
May 2, 2024 View Glaukos Corp (www.glaukos.com) location in California, United States , revenue, industry and description. Find related and similar companies as well as employees …See details»
Glaukos Charitable Foundation | About Us | Glaukos
The Glaukos Charitable Foundation is a philanthropic organization dedicated to helping the visually impaired and others in need. ... Glaukos has contributed more than 7,600 devices to underserved glaucoma patients in 54 different countries. …See details»
Glaukos - Leadership Team - The Org
The Leadership Team at Glaukos is responsible for steering the company's strategic vision and operational execution in the ophthalmic market. Comprising top executives from various …See details»
Glaukos Announces Executive Leadership Changes - Business Wire
Feb 7, 2022 Under his leadership, Glaukos has successfully built a best-in-class commercial organization and significantly expanded its direct sales infrastructure into 17 countries. Mr.See details»
Glaukos - Contacts, Employees, Board Members, Advisors & Alumni
Glaukos is a glaucoma treatment company developing micro-bypass therapies to moderate the intraocular pressures that help preserve vision. ... Chrome Extension. Solutions. Products. …See details»
Q&A With Glaukos CEO Thomas Burns - Glaucoma Today
In June 2015, Glaukos completed its initial public offering and began trading on the New York Stock Exchange under the ticker symbol GKOS. The milestone marked the culmination of 17 …See details»
Glaukos Announces Executive Leadership Changes
Feb 7, 2022 Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal …See details»
Our History | About Us - Glaukos
Glaukos.com: A Stripe cookie set for fraud prevention purposes and to help access the risk associated with an attempted transaction: 1 year: lpv: glaukos.com: A Pardot cookie set for …See details»
Glaukos Patient Services
Glaukos Patient Services (GPS) is an individualized support program for patients with glaucoma. Get started with GPS! Enrollment. Complete the enrollment forms that your doctor’s office …See details»
What 11 Analyst Ratings Have To Say About Glaukos
3 days ago Glaukos Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to …See details»
Glaukos price target raised to $175 from $153 at Stifel
3 days ago Stifel analyst Thomas Stephan raised the firm’s price target on Glaukos to $175 from $153 and keeps a Buy rating on the shares. The firm says that with the shares at all-time …See details»
Glaukos - Glaukos to Support World Glaucoma Week with Patient …
Mar 8, 2021 Glaukos is pursuing FDA approval for additional MIGS surgical and sustained pharmaceutical therapy pipeline products, all of which are investigational in the United States. …See details»